Get the Stockscreener App
1.85
0.54%
0.01
After Hours:
1.82
-0.03
-1.62%
Bullfrog Ai Holdings Inc stock is traded at $1.85, with a volume of 147.24K.
It is up +0.54% in the last 24 hours and down -11.06% over the past month.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
See More
Previous Close:
$1.84
Open:
$1.8
24h Volume:
147.24K
Relative Volume:
0.14
Market Cap:
$15.63M
Revenue:
-
Net Income/Loss:
$-6.07M
P/E Ratio:
-2.2024
EPS:
-0.84
Net Cash Flow:
$-5.54M
1W Performance:
+11.45%
1M Performance:
-11.06%
6M Performance:
-21.28%
1Y Performance:
-35.31%
1-Day Range:
$1.76
$1.85
1-Week Range:
$1.55
$1.85
52-Week Range:
$1.2268
$4.84
Bullfrog Ai Holdings Inc Stock (BFRG) Company Profile
Name
Bullfrog Ai Holdings Inc
Sector
Industry
Phone
(301) 367-2055
Address
325 ELLINGTON BLVD., GAITHERSBURG
Compare BFRG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BFRG
Bullfrog Ai Holdings Inc
|
1.85 | 15.63M | 0 | -6.07M | -5.54M | -0.84 |
|
VEEV
Veeva Systems Inc
|
227.54 | 34.18B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
56.65 | 9.62B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
52.90 | 7.09B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
85.87 | 6.94B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.02 | 6.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Bullfrog Ai Holdings Inc Stock (BFRG) Latest News
Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Short Interest Up 18.7% in March - Defense World
Join Bullfrog AI's Exclusive Live Investor Webinar and Q&A Session on April 23 - The Manila Times
BullFrog AI CEO to Showcase Johns Hopkins-Backed Drug Development Platform That's Revolutionizing Biopharma - Stock Titan
Join Bullfrog AI’s Exclusive Live Investor Webinar and Q&A Session on April 23 - Yahoo Finance
15,000 Shares in Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Purchased by Raymond James Financial Inc. - Defense World
Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Corsicana Daily Sun
Bullfrog AI Holdings Inc (BFRG) Shares Rise Despite Market Challenges - News Heater
Bullfrog AI CEO Vininder Singh sells $7,686 in common stock - Investing.com Australia
Bullfrog AI CEO Vininder Singh sells $7,686 in common stock By Investing.com - Investing.com India
Bullfrog AI CEO Vininder Singh sells $66,407 in stock By Investing.com - Investing.com Canada
Bullfrog AI CEO Vininder Singh sells $66,407 in stock - Investing.com Australia
BFRG stock touches 52-week low at $1.4 amid market challenges - Investing.com Australia
BFRG stock touches 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa
WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million - Quantisnow
AI Influence on Medical Diagnostics Generating Billion - GlobeNewswire
AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs - Financial Content
Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Short Interest Down 28.2% in February - Defense World
Bullfrog AI Holdings Inc. (BFRG) reports earnings - Quartz
Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Sees Significant Increase in Short Interest - Defense World
BullFrog AI partners with Eleison to enhance Phase III trial - MSN
BullFrog AI Partners With Eleison Pharmaceuticals To Optimize Phase 3 Pancreatic Cancer Trial - Nasdaq
BullFrog AI and Eleison Pharmaceuticals Enter Agreement to Collaborate to Optimize Pivotal Phase 3 Trial - The Manila Times
Can AI Technology Improve Pancreatic Cancer Trial Success? BullFrog's New Partnership Targets Deadly Disease - StockTitan
Bullfrog AI Holdings, Inc. (BFRG) to Discuss Breakthrough Psychiatric Research in Fireside Chat on March 5 - Insider Monkey
The AI Arms Race: How DeepSeek and Grok Are Shaking Up Wall Street - Zaman
The AI Race Intensifies: From Revolutionary Chatbots to Groundbreaking Medical Insights - Smartphone Magazine
10 Buzzing AI Stocks Dominating Headlines - Insider Monkey
Taking a look at what insiders are doing to gauge the Bullfrog AI Holdings Inc (BFRG)’s direction - Knox Daily
Can BullFrog AI Continue to Leap Higher? - Zacks Investment Research
Taking on analysts’ expectations and winning: Bullfrog AI Holdings Inc (BFRG) - SETE News
Understanding BFRG’s financial ratios: A beginner’s guide - US Post News
Bullfrog AI Holdings Inc (BFRG) Stock: From Low to High in 52 Weeks - The InvestChronicle
Bullfrog AI Holdings Inc (BFRG) Stock: Analyzing the Market Value - The News Heater
Bullfrog AI Holdings Insiders Benefitted From Selling Stock At US$2.41 - Simply Wall St
Press Release Distribution & PR Platform - ACCESS Newswire
BullFrog AI to Present at Benzinga All Access Event on Friday, February 17 - ACCESS Newswire
BullFrog AI Enters into Licensing Agreement with Johns Hopkins University for Use of Novel Formulation of Mebendazole for Treatment of Cancer - ACCESS Newswire
BullFrog AI Partners with J. Craig Venter Institute to Develop Colorectal Cancer Therapeutic - ACCESS Newswire
BullFrog AI to Present at Biotech Showcase and RESI JPM During JP Morgan Week - The Manila Times
BullFrog AI to Showcase Revolutionary AI-Powered Drug Development Platform at JPM Healthcare Conference - StockTitan
Bullfrog AI Sends Letter to Stockholders, Highlighting Achievements and Strategic Direction - Defense World
Bullfrog AI CEO: 2025 focus will remain on AI-driven solution commercialization - Yahoo Finance
BullFrog AI Issues Letter to Stockholders - EIN News
BullFrog AI Expands AI Platform, Secures Johns Hopkins Tech License & Advances Drug Pipeline - StockTitan
Certain Common Stock of Bullfrog AI Holdings, Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2024. - Marketscreener.com
BullFrog AI Holdings Appoints Josh Blacher as CFO - citybiz
BullFrog AI Names Josh Blacher as New CFO - TipRanks
Bullfrog Ai Holdings Inc Stock (BFRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
1.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):